Cat.#: ACPP-1502
Despition | DAG1 Human Recombinant |
SIZE | 2 µg |
Purity | Purity as determined by densitometric image analysis is > 90%. |
Form | Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1312 | Human GDNF Protein (AC1312) | 2 µg | inquiry |
ACPP-1175 | Recombinant Mouse Syndecan-1 Protein (Fc Tag) (AC1175) | 50 µg | inquiry |
ACPP-1342 | ORP150 Blocking Peptide (AC1342) | 250 µg | inquiry |
ACPP-1016 | Synthetic Nanodisc Human GnRHR Protein (AC1016) | 10 µg | inquiry |
ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
ACPP-1219 | Prominin 1 Blocking Peptide (AC1219) | 250 µg | inquiry |
ACPP-1404 | Human p59-Fyn Protein (AC1404) | 2 µg | inquiry |
ACPP-1161 | Recombinant Human DLK-1 Protein (6×His Tag) (AC1161) | 50 µg | inquiry |
ACPP-1768 | Human SNAP25 Protein (AC1768) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.